Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Oct 1;200(7):796-798.
doi: 10.1164/rccm.201905-0957ED.

Can Macrolide Antibiotics Prevent Hospital Readmissions?

Affiliations
Editorial

Can Macrolide Antibiotics Prevent Hospital Readmissions?

Jadwiga A Wedzicha et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Rothnie KJ, Müllerová H, Smeeth L, Quint JK. Natural history of chronic obstructive pulmonary disease exacerbations in a general practice-based population with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;198:464–471. - PMC - PubMed
    1. Hartl S, Lopez-Campos JL, Pozo-Rodriguez F, Castro-Acosta A, Studnicka M, Kaiser B, et al. Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD audit. Eur Respir J. 2016;47:113–121. - PubMed
    1. Aaron SD, Vandemheen KL, Maltais F, Field SK, Sin DD, Bourbeau J, et al. TNFα antagonists for acute exacerbations of COPD: a randomised double-blind controlled trial. Thorax. 2013;68:142–148. - PubMed
    1. Mackay AJ, Patel ARC, Singh R, Sapsford RJ, Donaldson GC, Prasad N, et al. Randomized double-blind controlled trial of roflumilast at acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;196:656–659. - PubMed
    1. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161:1608–1613. - PubMed